Search

Search Constraints

You searched for: Author/Creator Goossens, A.

Search Results

2. An orally bioavailable ENPP1-selective inhibitor demonstrates superior immune preservation effects over STING agonists and confers antitumor efficacy in combination with other therapies in syngeneic tumor models. (October 2022)

10. Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices. (6th May 2021)